Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis

Huan Ming Hsu, Chi Ming Chu, Yu Jia Chang, Jyh Cherng Yu, Chien Ting Chen, Chen En Jian, Chia Yi Lee, Yueh Tao Chiang, Chi Wen Chang, Yu Tien Chang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Gene co-expression network analysis (GCNA) can detect alterations in regulatory activities in case/control comparisons. We propose a framework to detect novel genes and networks for predicting breast cancer recurrence. Thirty-four prognosis candidate genes were selected based on a literature review. Four Gene Expression Omnibus Series (GSE) microarray datasets (n = 920) were used to create gene co-expression networks based on these candidates. We applied the framework to four comparison groups according to node (+/−) and recurrence (+/−). We identified a sub-network containing two candidate genes (LST1 and IGHM) and six novel genes (IGHA1, IGHD, IGHG1, IGHG3, IGLC2, and IGLJ3) related to B cell-specific immunoglobulin. These novel genes were correlated with recurrence under the control of node status and were found to function as tumor suppressors; higher mRNA expression indicated a lower risk of recurrence (hazard ratio, HR = 0.87, p = 0.001). We created an immune index score by performing principle component analysis and divided the genes into low and high groups. This discrete index significantly predicted relapse-free survival (RFS) (high: HR = 0.77, p = 0.019; low: control). Public tool KM Plotter and TCGA-BRCA gene expression data were used to validate. We confirmed these genes are correlated with RFS and distal metastasis-free survival (DMFS) in triple-negative breast cancer (TNBC) and general breast cancer.

Original languageEnglish
Article number4484
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Triple Negative Breast Neoplasms
Immunoglobulin Genes
Neoplasm Genes
Biomarkers
Gene Expression
Recurrence
Genes
Breast Neoplasms
Gene Regulatory Networks
Immunoglobulins
B-Lymphocytes
Neoplasm Metastasis
Messenger RNA

ASJC Scopus subject areas

  • General

Cite this

Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. / Hsu, Huan Ming; Chu, Chi Ming; Chang, Yu Jia; Yu, Jyh Cherng; Chen, Chien Ting; Jian, Chen En; Lee, Chia Yi; Chiang, Yueh Tao; Chang, Chi Wen; Chang, Yu Tien.

In: Scientific Reports, Vol. 9, No. 1, 4484, 01.12.2019.

Research output: Contribution to journalArticle

Hsu, Huan Ming ; Chu, Chi Ming ; Chang, Yu Jia ; Yu, Jyh Cherng ; Chen, Chien Ting ; Jian, Chen En ; Lee, Chia Yi ; Chiang, Yueh Tao ; Chang, Chi Wen ; Chang, Yu Tien. / Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. In: Scientific Reports. 2019 ; Vol. 9, No. 1.
@article{89335a7f1dab4677b2eb5b2815b99f02,
title = "Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis",
abstract = "Gene co-expression network analysis (GCNA) can detect alterations in regulatory activities in case/control comparisons. We propose a framework to detect novel genes and networks for predicting breast cancer recurrence. Thirty-four prognosis candidate genes were selected based on a literature review. Four Gene Expression Omnibus Series (GSE) microarray datasets (n = 920) were used to create gene co-expression networks based on these candidates. We applied the framework to four comparison groups according to node (+/−) and recurrence (+/−). We identified a sub-network containing two candidate genes (LST1 and IGHM) and six novel genes (IGHA1, IGHD, IGHG1, IGHG3, IGLC2, and IGLJ3) related to B cell-specific immunoglobulin. These novel genes were correlated with recurrence under the control of node status and were found to function as tumor suppressors; higher mRNA expression indicated a lower risk of recurrence (hazard ratio, HR = 0.87, p = 0.001). We created an immune index score by performing principle component analysis and divided the genes into low and high groups. This discrete index significantly predicted relapse-free survival (RFS) (high: HR = 0.77, p = 0.019; low: control). Public tool KM Plotter and TCGA-BRCA gene expression data were used to validate. We confirmed these genes are correlated with RFS and distal metastasis-free survival (DMFS) in triple-negative breast cancer (TNBC) and general breast cancer.",
author = "Hsu, {Huan Ming} and Chu, {Chi Ming} and Chang, {Yu Jia} and Yu, {Jyh Cherng} and Chen, {Chien Ting} and Jian, {Chen En} and Lee, {Chia Yi} and Chiang, {Yueh Tao} and Chang, {Chi Wen} and Chang, {Yu Tien}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-40826-w",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis

AU - Hsu, Huan Ming

AU - Chu, Chi Ming

AU - Chang, Yu Jia

AU - Yu, Jyh Cherng

AU - Chen, Chien Ting

AU - Jian, Chen En

AU - Lee, Chia Yi

AU - Chiang, Yueh Tao

AU - Chang, Chi Wen

AU - Chang, Yu Tien

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Gene co-expression network analysis (GCNA) can detect alterations in regulatory activities in case/control comparisons. We propose a framework to detect novel genes and networks for predicting breast cancer recurrence. Thirty-four prognosis candidate genes were selected based on a literature review. Four Gene Expression Omnibus Series (GSE) microarray datasets (n = 920) were used to create gene co-expression networks based on these candidates. We applied the framework to four comparison groups according to node (+/−) and recurrence (+/−). We identified a sub-network containing two candidate genes (LST1 and IGHM) and six novel genes (IGHA1, IGHD, IGHG1, IGHG3, IGLC2, and IGLJ3) related to B cell-specific immunoglobulin. These novel genes were correlated with recurrence under the control of node status and were found to function as tumor suppressors; higher mRNA expression indicated a lower risk of recurrence (hazard ratio, HR = 0.87, p = 0.001). We created an immune index score by performing principle component analysis and divided the genes into low and high groups. This discrete index significantly predicted relapse-free survival (RFS) (high: HR = 0.77, p = 0.019; low: control). Public tool KM Plotter and TCGA-BRCA gene expression data were used to validate. We confirmed these genes are correlated with RFS and distal metastasis-free survival (DMFS) in triple-negative breast cancer (TNBC) and general breast cancer.

AB - Gene co-expression network analysis (GCNA) can detect alterations in regulatory activities in case/control comparisons. We propose a framework to detect novel genes and networks for predicting breast cancer recurrence. Thirty-four prognosis candidate genes were selected based on a literature review. Four Gene Expression Omnibus Series (GSE) microarray datasets (n = 920) were used to create gene co-expression networks based on these candidates. We applied the framework to four comparison groups according to node (+/−) and recurrence (+/−). We identified a sub-network containing two candidate genes (LST1 and IGHM) and six novel genes (IGHA1, IGHD, IGHG1, IGHG3, IGLC2, and IGLJ3) related to B cell-specific immunoglobulin. These novel genes were correlated with recurrence under the control of node status and were found to function as tumor suppressors; higher mRNA expression indicated a lower risk of recurrence (hazard ratio, HR = 0.87, p = 0.001). We created an immune index score by performing principle component analysis and divided the genes into low and high groups. This discrete index significantly predicted relapse-free survival (RFS) (high: HR = 0.77, p = 0.019; low: control). Public tool KM Plotter and TCGA-BRCA gene expression data were used to validate. We confirmed these genes are correlated with RFS and distal metastasis-free survival (DMFS) in triple-negative breast cancer (TNBC) and general breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85062965117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062965117&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-40826-w

DO - 10.1038/s41598-019-40826-w

M3 - Article

C2 - 30872752

AN - SCOPUS:85062965117

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4484

ER -